目的：探讨降纤酶治疗急性脑梗死的疗效。
Objective:To analyze the curative effect on cerebral infarction with defibrase.
目的观察降纤酶治疗急性脑梗死的临床疗效。
Objecitive To observe the effect of defibrase on acute cerebral infarction(ACI).
如果治疗期间有颅内外出血则立即停用降纤酶。
Defibrase should be stopped at once if any hemorrhage take place.
目的：观察力源精纯降纤酶治疗缺血性脑梗死的临床疗效。
Objective:To observe the effects of Liyuan purified difibrinogease in treatment of cerebral infarction.
目的探讨降纤酶对脑梗死的溶栓效果、用药时间窗及安全性。
Objective To discuss the thrombolysis effect, drug using window, and safety for cerebral infarction.
目的对4 0例急性脑梗死患者应用降纤酶治疗，监测治疗前后凝血指标变化。
Objective To detect agglutinative index before and after treatment with defibrasee to 40 patients with acute cerebral infarction.
方法应用降纤酶治疗40名脑梗死患者，分别记录治疗前后血液流变学的变化。
Methods40 patients with acute ischemic stroke were treated by defibrase and the change of hemorheology was recorded before and after the treatment respectively.
降纤酶有明显降低血黏度、纤维蛋白原含量、红细胞聚集性、血小板聚集作用。
Defibrase can effectively reduce blood viscosity, content of fibrinogen, hemocyte aggregation and platelet aggregation.
结论降纤酶可降低纤维蛋白原、抑制红细胞聚集、降低血液粘度，从而改善微循环。
Conclusion Defibris could decrease fibrinogen, inhibit red blood cell accumulating, decrease viscosity of whole blood, as a result improved microcirculation.
结论：精纯抗栓酶与降纤酶这两种蛇毒制剂的疗效相近，使用后使纤维蛋白原降低的作用时间均较短。
Conclusion: Ahalsantinfarctasel and Difibrinogenase have almost equal curative effect and both have the short effective duration to reduce the fibrinogen.
结论：降纤酶治疗急性脑梗死疗效确切，能显著降低纤维蛋白原，改善全血黏度，降低致残率，不良反应少。
Conclusion: Defibrase can significantly decrease fibrinogen, improve whole blood viscosity, and decrease disability rate. With little side effect, it is effective on acute cerebral infarction.
结论：降纤酶治疗急性脑梗死疗效确切，能显著降低纤维蛋白原，改善全血黏度，降低致残率，不良反应少。
Conclusion: Defibrase can significantly decrease fibrinogen, improve whole blood viscosity, and decrease disability rate. With little side effect, it is effective on acute cerebral infarction.
应用推荐